$ACON
Aclarion, Inc. Common Stock
XNAS•Health Care•Services-Medical Laboratories
$2.35
▲+2.62%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAclarion, Inc. Common Stock
XNAS•Health Care•Services-Medical Laboratories
Why is ACON up today? It is at $2.35 (+2.62%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ACON spikes, and full due diligence on ACON — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ACON 6 times in the last 30 days. Create a free account to track $ACON, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ACON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAclarion, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Williams Amanda M Director | Bought (open market) | +6K 0.2% of company | added 29% | 26K | $16K at $2.73 | Aug 17, 26 |
Gould Gregory A Officer | Bought (open market) | +10K 0.3% of company | added 20% | 60K | $25K at $2.45 | Aug 14, 26 |
Ness Brent Officer | Bought (open market) | +5K 0.2% of company | added 4.9% | 112K | $12K at $2.31 | Aug 13, 26 |
Neal David K Director | Bought (open market) | +8K 0.3% of company | added 33% | 30K | $18K at $2.40 | Aug 13, 26 |
Wesemann William Director | Bought (open market) | +2K 0.07% of company | added 10.0% | 24K | $5K at $2.34 | Aug 13, 26 |
Bond Ryan Director | Bought (open market) | +21K 0.7% of company | added 38% | 76K | $50K at $2.37 | Aug 13, 26 |
Neal David K Director | Acquired (grant/award) | +20K 0.7% of company | added 100% | 23K | n/a | Jun 11, 26 |
Deitsch Stephen Director | Acquired (grant/award) | +20K 0.7% of company | n/a | 20K | n/a | Jun 11, 26 |
Thramann Jeffrey John Officer | Acquired (grant/award) | +100K 3.5% of company | n/a | 100K | n/a | Jun 11, 26 |
Gould Gregory A Officer | Acquired (grant/award) | +50K 1.7% of company | n/a | 50K | n/a | Jun 11, 26 |
Ness Brent Officer | Acquired (grant/award) | +100K 3.5% of company | added 100% | 106K | n/a | Jun 11, 26 |
Breidbart Scott Director | Acquired (grant/award) | +20K 0.7% of company | added 100% | 26K | n/a | Jun 11, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in services-medical laboratories, closest in size first.
Here is the latest on ACON from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ACON today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ACON last traded at $2.35, up 2.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aclarion, Inc. Common Stock (ACON) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ACON Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ACON 6 times in the last 30 days.
ACON (Aclarion, Inc. Common Stock) trades on XNAS, with a market cap of about $7M in the Services-Medical Laboratories sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ACON for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ACON discussion
Sign in to ask a question or join the discussion.